Erleada 240 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQGYY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,705
Award facts
- Contract value 100% obligated
- $14,704.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $14,704.98, represents a non-competitive set-aside contract and is scheduled for completion by August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp functions as a primary pharmaceutical distributor for federal medical procurement, supplying a broad range of medications and medical supplies to support military and veteran healthcare systems. The company's substantial IDC with DLA Troop Support Medical enables it to serve as a global pharmaceutical vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This particular delivery order for Erleada, a prescription prostate cancer medication, exemplifies the company's role in providing specialized therapeutic pharmaceuticals across multiple therapeutic domains to support federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FQGYY?
SPE2DB25FQGYY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FQGYY worth?
The government has obligated $14,705 on SPE2DB25FQGYY.
Is contract SPE2DB25FQGYY an order under another contract?
Yes. SPE2DB25FQGYY is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQGYY competed?
The extent of competition for SPE2DB25FQGYY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award